Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206843 · ClinicalTrials.gov registry record · NA
Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)
A NA study, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- NA
- Development phase
- 630
- Enrollment target
NCT00206843: Completed NA study, sponsored by Abbott RDx Cardiometabolic.
NCT00206843 is a NA study that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 630 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00206843, a NA study, has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- NA
- Development phase
- 630 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether physicians can make more informed treatment, admission, and discharge decisions related to patient care by having serial Triage® BNP test results available to assess disease severity, while patients are being treated for HF in the Emergency Department and/or during their admission. This is believed to lead to a better outcome as well as more efficient and cost-effective treatment.
Interventions
- DEVICE Triage BNP Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-08 |
| Phase | NA |
What the finished NCT00206843 record still lists
NCT00206843 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Triage BNP Test is the first listed.
NCT00206843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00206843 about?
NCT00206843 is a clinical study titled "Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)". The purpose of this study is to test whether physicians can make more informed treatment, admission, and discharge decisions related to patient care by having serial Triage® BNP test results available to assess disease severity, while patients are being treated for HF in the Emergency Department and...
What is the current status of trial NCT00206843?
This trial is currently completed. It is a NA study. The enrollment target is 630 participants. The study started on 2004-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00206843?
The interventions under investigation include: Triage BNP Test (DEVICE).
Who is sponsoring clinical trial NCT00206843?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00206843's enrollment target sits among peer trials
630 159th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia